Inclusion Criteria:  Patients with a diagnosed mutation in the CTNNB1 gene. Patients whose parents/caregivers were informed about the aims of the study and have signed the Informed consent form.  Exclusion Criteria:  Patients who do not have a diagnosed mutation in the CTTNB1 gene. Patients whose caregivers have not signed the Informed consent form.